Reading this on a mobile device? Try our optimized mobile version here:

February 20, 2013
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  Clinical News & Research 
  • Nuclear medicine physician recognized for groundbreaking research
    Dr. Nasima Akhter, senior medical officer at Dhaka Medical College's Center for Nuclear Medicine and Ultrasound in Bangladesh, was one of five biological researchers honored at the American Association for the Advancement of Science's annual meeting. Akhter's work focuses on the use of nuchal translucency-based testing to detect congenital abnormalities during the first three months of pregnancy. Akhter is also exploring the use of inactive iodine therapy combined with radioiodine in treating Graves' disease. (free registration) (2/19) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • RefleXion uses cloud system to accelerate device development
    RefleXion Medical said the use of CliQr's CloudCenter platform allowed it to conduct cancer treatment simulations overnight instead of over the usual two to three weeks. RefleXion is developing a PET-guided radiation-therapy system for tumor treatment. Company officials hope the faster simulations will help it bring the system to market sooner. With the simulations, "we can have a very good sense of how our device is going to perform when it's treating patients," said Akshay Nanduri, RefleXion co-founder and vice president of business development. eWeek (2/19) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  International Developments 
  Health Policy 
  • FDA issues draft guidance on third-party device review program
    The FDA has released draft guidance on changes to its program to accredit third-party entities to review certain medical device applications. The draft guidance, based on the International Medical Device Regulators Forum's proposal to create a unified program for medtech auditors, covers compliance with the FDA Safety and Innovation Act, including a provision regarding third-party firm accreditation. Firms must seek reaccreditation every three years. Clinica (subscription required) (2/19) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • ONC voluntary guidelines for HIE will be issued in coming months
    The Office of the National Coordinator for Health IT will release voluntary guidelines for health information exchange in the first half of 2013. The guidelines, given instead of a formal rule, will allow for feedback and sharing of best practices in the health care community. The ONC will update guidelines periodically in an effort to "get something out to reduce uncertainty and let people know what we're thinking," said ONC policy analyst Steve Posnack. (2/15) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • SNMMI's 2013 Annual Meeting offers more than 100 CE sessions
    Essential by Design! With more than 100 CE sessions available, the latest research across all modalities, presentations from leading experts, countless networking opportunities and one of the largest exhibit halls in the profession, the SNMMI Annual Meeting is your one stop for learning and networking. Register today and be part of the premier educational and scientific event in nuclear and molecular imaging. LinkedInFacebookTwitterEmail this Story
  • Special symposium: Photons Across Medicine — April 15, 2013
    Join SNMMI for a special symposium on the use of photons across medical imaging, taking place during the Optics in the Life Sciences Congress, April 14-18 in Waikoloa Beach, Hawaii. During this congress, you'll explore the latest advances in molecular probe development, life science imaging, novel and more powerful optical instrumentation and its application to study fundamental biological processes. Clinical investigations will be presented. Register today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

We must travel in the direction of our fear."
--John Berryman,
American poet and scholar

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®  Legal Information